Product Information
TETRACYCLINE 500 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.6275 per EA under NDC 00591247501. Its NADAC has been published 525 times since Jun 8, 2016.
Strength
500 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591247501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TETRACYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA061837On Market Since
8/15/2011
Pharmacological Classes
Price Statistics
The NADAC for TETRACYCLINE 500 MG CAPSULE has been published 525 times since Jun 8, 2016, and over the history we have for it it has declined 94.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6275 per EA |
|---|---|
| All-time high | $11.1479 (Jun 15, 2016) |
| All-time low | $0.6275 (Jun 17, 2026) |
| 52-week high | $0.7825 |
| 52-week low | $0.6275 |
| Median price | $1.5934 |
| Average price | $2.8026 |
| Largest weekly change | +103.4% (Dec 22, 2021) |
| Weeks tracked | 525 |
| Tracking since | Jun 8, 2016 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TETRACYCLINE 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TETRACYCLINE 500 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.6275 per EA (NDC 00591247501), effective Jun 24, 2026.
How has the price of TETRACYCLINE 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TETRACYCLINE 500 MG CAPSULE has declined 94.4%. It has been tracked across 525 weekly CMS publications since Jun 8, 2016.
What are the highest and lowest recorded NADAC prices for TETRACYCLINE 500 MG CAPSULE?
Since Jun 8, 2016, the NADAC for TETRACYCLINE 500 MG CAPSULE has ranged from a low of $0.6275 (Jun 17, 2026) to a high of $11.1479 (Jun 15, 2016), with a median of $1.5934 per EA.
Are there cheaper alternatives to TETRACYCLINE 500 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as TETRACYCLINE 500 MG CAPSULE, but none are currently priced below it.
Who manufactures TETRACYCLINE 500 MG CAPSULE?
TETRACYCLINE 500 MG CAPSULE (NDC 00591247501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification